Annika M Jodicke
Overview
Explore the profile of Annika M Jodicke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie J, Lopez-Guell K, Dedman D, Duarte-Salles T, Kolde R, Lopez-Blasco R, et al.
EClinicalMedicine
. 2024 Nov;
77:102903.
PMID: 39552716
Background: The World Health Organisation (WHO) has identified a range of symptomatic manifestations to aid in the clinical diagnosis of post-COVID conditions, herein referred to as post-acute COVID-19 symptoms. We...
2.
Guo Y, Strauss V, Catala M, Jodicke A, Khalid S, Prieto-Alhambra D
Front Pharmacol
. 2024 Nov;
15:1395707.
PMID: 39529889
Introduction: Machine learning (ML) methods are promising and scalable alternatives for propensity score (PS) estimation, but their comparative performance in disease risk score (DRS) estimation remains unexplored. Methods: We used...
3.
Guo Y, Raventos B, Catala M, Elhussein L, Lopez-Guell K, Tan E, et al.
Pharmacoepidemiol Drug Saf
. 2024 Oct;
33(10):e70022.
PMID: 39414581
Purpose: To illustrate the interest in using interrupted time series (ITS) methods, this study evaluated the impact of the UK MHRA's March 2019 Risk Minimisation Measures (RMM) on fluoroquinolone usage....
4.
Barclay N, Catala M, Jodicke A, Prieto-Alhambra D, Newby D, Delmestri A, et al.
Ther Adv Med Oncol
. 2024 Jun;
16:17588359241253115.
PMID: 38832300
Background: The COVID-19 pandemic affected cancer screening, diagnosis and treatments. Many surgeries were substituted with bridging therapies during the initial lockdown, yet consideration of treatment side effects and their management...
5.
Burkard T, Lopez-Guell K, Gorbachev A, Bellas L, Jodicke A, Burn E, et al.
Pharmacoepidemiol Drug Saf
. 2024 May;
33(6):e5809.
PMID: 38773798
Purpose: We aimed to develop a standardized method to calculate daily dose (i.e., the amount of drug a patient was exposed to per day) of any drug on a global...
6.
Xie J, Mothe B, Alcalde Herraiz M, Li C, Xu Y, Jodicke A, et al.
Nat Commun
. 2024 May;
15(1):4031.
PMID: 38740772
The rapid global distribution of COVID-19 vaccines, with over a billion doses administered, has been unprecedented. However, in comparison to most identified clinical determinants, the implications of individual genetic factors...
7.
Trinh N, Jodicke A, Catala M, Mercade-Besora N, Hayati S, Lupattelli A, et al.
Lancet Respir Med
. 2024 Apr;
12(5):e33-e34.
PMID: 38614106
No abstract available.
8.
Barclay N, Moncusi M, Jodicke A, Prieto-Alhambra D, Raventos B, Newby D, et al.
Front Oncol
. 2024 Apr;
14:1370862.
PMID: 38601756
Introduction: The COVID-19 pandemic had collateral effects on many health systems. Cancer screening and diagnostic tests were postponed, resulting in delays in diagnosis and treatment. This study assessed the impact...
9.
Mercade-Besora N, Guo Y, Du M, Li X, Ramirez-Anguita J, Moreno A, et al.
Arthritis Care Res (Hoboken)
. 2024 Mar;
76(8):1173-1178.
PMID: 38523562
Objective: We studied whether the use of hydroxychloroquine (HCQ) for COVID-19 resulted in supply shortages for patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Methods: We used US...
10.
Mercade-Besora N, Li X, Kolde R, Trinh N, Sanchez-Santos M, Man W, et al.
Heart
. 2024 Mar;
110(9):635-643.
PMID: 38471729
Objective: To study the association between COVID-19 vaccination and the risk of post-COVID-19 cardiac and thromboembolic complications. Methods: We conducted a staggered cohort study based on national vaccination campaigns using...